Drug Type Bispecific antibody |
Synonyms |
Target |
Mechanism F10 inhibitors(Coagulation factor X inhibitors), F8 inhibitors(Coagulation factor VIII inhibitors), factor IX inhibitors(Coagulation factor IX inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hemophilia A | Preclinical | GB | 13 Dec 2017 |